Syneos Health
$42.699876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$42.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.68 (+4.10%) As of 12:05 PM EDT today
+$1.68 (+4.10%) Today
Why Robinhood?
You can buy or sell Syneos Health and other stocks, options, ETFs, and crypto commission-free!
About SYNH
Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. Read More The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded on August 13, 2010 and is headquartered in Morrisville, NC.
Employees
24,000
Headquarters
Morrisville, North Carolina
Founded
2010
Market Cap
4.28B
Price-Earnings Ratio
32.82
Dividend Yield
—
Average Volume
857.86K
High Today
$42.99
Low Today
$40.69
Open Price
$41.84
Volume
177.57K
52 Week High
$74.25
52 Week Low
$30.02
Collections
Analyst Ratings
67%
of 15 ratings
Buy
67%
Hold
33%
Sell
0%
SYNH Earnings
$0.00
$0.34
$0.69
$1.03
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, Pre-Market